Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 51,800 | 14,384 | -6,956 | 3,991 | 62,870 |
| Depreciation Amortization | 38,200 | 28,155 | 17,770 | 8,840 | 35,335 |
| Income taxes - deferred | 5,200 | 4,814 | 547 | 2,964 | 3,464 |
| Accounts receivable | -22,400 | 45,035 | 53,933 | 51,207 | -64,351 |
| Accounts payable and accrued liabilities | -14,800 | -1,305 | 11,287 | 385 | 4,749 |
| Other Working Capital | -44,300 | 11,233 | 26,487 | 26,047 | -67,846 |
| Other Operating Activity | 40,900 | -35,065 | -62,893 | -51,263 | 68,296 |
| Operating Cash Flow | $54,600 | $67,251 | $40,175 | $42,171 | $42,517 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -76,200 | -56,243 | -39,246 | -18,214 | -44,812 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -650 |
| Investing Cash Flow | $-76,200 | $-56,243 | $-39,246 | $-18,214 | $-45,462 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,000 |
| Common Stock Issued | 17,100 | 14,981 | 14,524 | 3,595 | 25,961 |
| Common Stock Repurchased | N/A | N/A | 0 | 0 | -100 |
| Other Financing Activity | -36,900 | -39,991 | 4,979 | 657 | 7,530 |
| Financing Cash Flow | $-19,800 | $-25,010 | $19,503 | $4,252 | $35,391 |
| Exchange Rate Effect | 100 | 139 | 168 | 11 | -150 |
| Beginning Cash Position | 312,800 | 312,795 | 312,795 | 312,795 | 280,499 |
| End Cash Position | 271,500 | 298,932 | 333,395 | 341,015 | 312,795 |
| Net Cash Flow | $-41,300 | $-13,863 | $20,600 | $28,220 | $32,296 |
| Free Cash Flow | |||||
| Operating Cash Flow | 54,600 | 67,251 | 40,175 | 42,171 | 42,517 |
| Capital Expenditure | -76,200 | -56,243 | -39,246 | -18,214 | -44,812 |
| Free Cash Flow | -21,600 | 11,008 | 929 | 23,957 | -2,295 |